News

Professor Zhang Ge, Associate Dean (Research) of Chinese Medicine, has secured a top funding amount of RMB 3 million, from the latest Shenzhen-Hong Kong-Macau Science and Technology Plan Project (Category C).

The exceptional awarded project was titled “Role of sclerostin structural loop3 in bone formation reduction and site-specific arterial stiffness increase under simulated weightlessness”. It aims to provide a precise molecular target that is safe for the cardiovascular system to combat bone loss due to weightlessness in space. It intends to support the development of innovative drugs (cardiovascular-safe sclerostin inhibitors) with China’s independent intellectual property rights. This is aimed at safeguarding the bone and cardiovascular health of astronauts in China's plan for a manned lunar landing by 2030.

The Shenzhen-Hong Kong-Macau Science and Technology Plan Project is managed by the Shenzhen Science and Technology Innovation Commission (SZSTI). SZSTI is the main administrative department for science and technology in Shenzhen, coordinating and overseeing the development of scientific and technological advancements and innovation capability building. It is responsible for promoting the construction of Shenzhen's independent innovation system and managing major national and provincial scientific technological projects and programmes.

The School is dedicated to advancing the frontiers of research and pushing the boundaries of knowledge. We extend our congratulations to Professor Zhang for his remarkable achievements.